Stock Price Forecast

Jan. 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Rain Oncology Inc chart...

About the Company

rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.

Exchange

NASDAQ

Website

rainthera.com

$413M

Total Revenue

38

Employees

$44M

Market Capitalization

-0.57

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $RAIN News

Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views

11mon ago, source: Hosted on MSN

Shares of Rain Oncology Inc (NASDAQ: RAIN) recovered in early trading on Tuesday, after having plummeted on disappointing cancer study data. Here are some key analyst takeaways from the company ...

Lexaria Appoints Nelson Cabatuan as Chief Financial Officer

1mon ago, source: Morningstar

Mr. Cabatuan has over 15 years of corporate finance and operations experience within the life sciences industry, most recently serving as SVP Finance and Operations at Rain Oncology, Inc., a late ...

Northwest Oklahoma hopes for rain as drought causes issues for farmers, ranchers

on MSN ago, source:

A slow start to the spring severe weather season helped many Oklahomans avoid storm damage, but the lack of rain has created ...

CSBR Champions Oncology, Inc.

2mon ago, source: Seeking Alpha

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its ...

Pyxis Oncology, Inc. (PYXS)

4d ago, source: Yahoo Finance

Sullivan, M.D BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to ...

CG Oncology, Inc.

2mon ago, source: CNN

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer.

Elevation Oncology, Inc.

11mon ago, source: CNN

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.

Oncology Pharma Inc ONPH

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ELEV Elevation Oncology, Inc.

18d ago, source: Seeking Alpha

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...